Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 1,920 shares at $547.29 ($1.1M) on 2026-09-30, disclosed to the SEC on 2026-10-01.
Scheduled sale ($1.1M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $547.29 | 400 | $219K | 20.7% |
| 2 | $548.25 | 280 | $154K | 14.5% |
| 3 | $549.40 | 240 | $132K | 12.5% |
| 4 | $550.47 | 400 | $220K | 20.8% |
| 5 | $551.50 | 160 | $88K | 8.4% |
| 6 | $552.63 | 120 |
| $66K |
| 6.3% |
| 7 | $553.78 | 113 | $63K | 5.9% |
| 8 | $554.70 | 207 | $115K | 10.9% |
| Total | $550.22 avg | 1,920 | $1.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-08 | $5.2M | — | Filing → |